Sickle cell anemia - Nursing Case Study
Pathophysiology
• Primary mechanism: Sickle cell anemia is caused by a mutation in the HBB gene, leading to the production of abnormal hemoglobin S (HbS). This results in erythrocyte deformation into a sickle shape under low oxygen conditions, causing rigidity and reducing the cells' ability to navigate capillaries effectively.
• Secondary mechanism: The sickled erythrocytes are prone to hemolysis, leading to chronic hemolytic anemia. This increases bilirubin levels, contributing to jaundice and an increased workload on the spleen, often resulting in splenomegaly and eventually functional asplenia.
• Key complication: Vaso-occlusive crises occur when sickled cells obstruct microcirculation, causing ischemia and severe pain. These episodes can lead to acute chest syndrome, stroke, and multi-organ damage, significantly impacting morbidity and mortality.
Patient Profile
Demographics:
32-year-old female, nurse
History:
• Key past medical history: Diagnosed with sickle cell anemia at age 2, history of multiple vaso-occlusive crises, acute chest syndrome, and avascular necrosis of the hip
• Current medications: Hydroxyurea, folic acid, morphine for pain management, prophylactic penicillin, L-glutamine oral powder
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe chest pain and difficulty breathing
• Key symptoms: Intense pain in the chest and back, shortness of breath, fever, fatigue, jaundice, swelling in hands and feet, headache
• Vital signs: Temperature 102.5°F, heart rate 130 bpm, respiratory rate 28 breaths per minute, blood pressure 88/54 mmHg, oxygen saturation 84% on room air
Section 1
Change in Patient Status:
Upon admission to the emergency department, the patient’s condition rapidly deteriorates. Her respiratory distress intensifies, and she becomes increasingly lethargic, struggling to maintain consciousness. Repeat vital signs show a further decline: oxygen saturation drops to 78% despite supplemental oxygen via non-rebreather mask, heart rate escalates to 145 bpm, and blood pressure plummets to 82/50 mmHg. Auscultation reveals diminished breath sounds on the right side with crackles, suggesting possible atelectasis or consolidation. The patient’s skin remains jaundiced, and new petechiae are noted on her lower extremities, indicating potential thrombocytopenia.
A stat chest X-ray is performed, revealing extensive bilateral infiltrates consistent with acute chest syndrome. Laboratory tests return with critical values: hemoglobin at 6.5 g/dL, white blood cell count elevated at 18,000/mm³ indicating possible infection or inflammation, and platelet count critically low at 48,000/mm³. Arterial blood gases reveal severe hypoxemia with a pH of 7.32, pCO2 of 60 mmHg, and pO2 of 55 mmHg, confirming respiratory acidosis. The patient is immediately transferred to the intensive care unit for closer monitoring and advanced interventions, including consideration for exchange transfusion and mechanical ventilation.
The medical team, aware of the complexity of managing such a severe sickle cell crisis, deliberates over the risks and benefits of aggressive interventions. They must weigh the potential for an exchange transfusion to rapidly reduce sickle hemoglobin levels against the risk of transfusion-related complications, given the patient's critical thrombocytopenia and potential for transfusion reactions. The decision-making process is complicated by the need to address potential infection sources swiftly, optimize pain management, and stabilize cardiorespiratory function amidst the backdrop of acute chest syndrome and systemic inflammatory response.
Section 2
Response to Interventions:
In the intensive care unit, the medical team initiates the exchange transfusion to decrease the circulating sickle hemoglobin and improve oxygenation. Simultaneously, the patient is started on broad-spectrum antibiotics to address the possibility of an underlying infection contributing to her acute chest syndrome. Mechanical ventilation is commenced to support her compromised respiratory function, with careful titration of settings to achieve optimal gas exchange while minimizing barotrauma risk. Despite these efforts, the patient's oxygen saturation remains precariously low, hovering around 82-85%, and her heart rate remains elevated at 135 bpm.
Hours into the interventions, the patient shows signs of increased agitation and confusion, which are concerning for worsening cerebral hypoxia or possible transfusion reaction. Her blood pressure stabilizes slightly at 90/55 mmHg with the administration of intravenous fluids and vasopressors, but her mental status does not improve significantly. Repeat laboratory tests reveal a slight increase in hemoglobin to 7.2 g/dL, but her platelet count continues to decline, now at 42,000/mm³. The white blood cell count remains elevated, and further workup is underway to identify any infectious pathogens.
The clinical team faces a critical juncture: they must re-evaluate the treatment strategy considering the limited improvement in oxygenation and the potential for multi-organ dysfunction. The possibility of acute multi-system organ failure looms, necessitating discussions about the escalation of care, including renal support or additional immunomodulatory therapies. The team considers consulting hematology and infectious disease specialists to re-assess the therapeutic approach and explore advanced options such as nitric oxide therapy or more targeted antimicrobial regimens. This complex scenario demands a dynamic and interdisciplinary approach, emphasizing the need for vigilant monitoring and rapid adaptation to the patient's evolving condition.
Section 3
As the ICU team continues to manage the patient's critical condition, a new complication arises. The patient begins to exhibit signs of acute kidney injury, likely precipitated by the combination of hypoxia, hypotension, and hemolysis. Urine output has decreased to less than 0.3 mL/kg/hr over the past four hours, and laboratory tests show a rising creatinine level now at 2.1 mg/dL, up from 1.0 mg/dL earlier in the day. Electrolytes reveal an increasing potassium level at 5.8 mmol/L, raising concerns for hyperkalemia, which could further destabilize the patient's already compromised cardiac function. The nephrology team is urgently consulted to evaluate the need for renal replacement therapy, and the critical care team initiates measures to manage the electrolyte imbalance, including the administration of calcium gluconate and insulin with glucose to stabilize cardiac membranes and promote intracellular potassium shift.
Simultaneously, the infectious disease team evaluates the patient, as repeat blood cultures grow Gram-negative rods, indicating a potential gram-negative sepsis complicating her sickle cell crisis. The team escalates antibiotic therapy to include coverage for Pseudomonas aeruginosa, given the high risk of resistant organisms in this setting. Despite these interventions, the patient's mental status continues to deteriorate, with a Glasgow Coma Scale score dropping to 8, necessitating intubation and sedation for airway protection and to facilitate mechanical ventilation.
The medical team faces the imperative to reassess and possibly intensify the current treatment regimen. Considering the multifactorial nature of the patient's condition, the team deliberates the use of adjunctive therapies such as nitric oxide for pulmonary vasodilation to improve oxygenation and the potential initiation of continuous renal replacement therapy (CRRT) to address fluid overload and metabolic derangements. With the patient's status declining, the team must balance aggressive intervention with the consideration of the patient's overall prognosis and potential for recovery, engaging in discussions with family members about goals of care and realistic expectations.
Section 4
As the medical team implements their comprehensive treatment plan, they closely monitor the patient's response to interventions, particularly focusing on the delicate balance required to stabilize her critical condition. Within the first few hours of initiating continuous renal replacement therapy (CRRT), there are encouraging signs of improvement in her metabolic parameters. The patient's serum potassium levels begin to normalize, dropping to 4.9 mmol/L, suggesting effective potassium clearance. Despite this positive development, fluid balance remains a challenge; her urine output remains scant, and the team must carefully titrate fluid removal to prevent hemodynamic instability. In parallel, the administration of nitric oxide shows a modest improvement in oxygenation parameters, with an increase in PaO2 levels from 60 mmHg to 72 mmHg, indicating enhanced pulmonary perfusion.
However, the relief is tempered by the emergence of new complications. The patient's blood pressure begins to fluctuate with episodes of severe hypotension, requiring continuous vasopressor support. Her mean arterial pressure intermittently dips below 60 mmHg, raising concerns about adequate organ perfusion. Moreover, her liver function tests reveal a concerning trend, with a significant elevation in liver enzymes, suggesting possible ischemic hepatitis or drug-induced liver injury. The team is now faced with the challenge of managing multiple organ dysfunctions while preventing further deterioration.
Simultaneously, the patient's neurological status remains a source of concern. Despite mechanical ventilation and sedation, the patient displays intermittent episodes of agitation, potentially indicating inadequate sedation or evolving intracranial pathology. A stat CT scan of the head is organized, and preliminary results reveal signs of cerebral edema. The critical care team must now consider interventions to manage intracranial pressure while continuing to support her multisystem failure. As they navigate these complexities, discussions with the family regarding the patient's prognosis and the intensity of care are initiated, ensuring that treatment aligns with the patient's values and preferences.
Section 5
As the medical team continues to grapple with the complexities of this case, the latest diagnostic results highlight new challenges. The stat CT scan of the head, performed in response to the patient's episodes of agitation, confirms moderate cerebral edema. This finding necessitates the urgent implementation of an intracranial pressure management protocol. The critical care team opts for a combination of hypertonic saline infusion and controlled ventilation strategies to mitigate the risk of further neurological compromise. Despite these interventions, the patient's neurological status remains tenuous, with Glasgow Coma Scale scores fluctuating between 8 and 10, indicating significant impairment.
Concurrently, the patient's liver function tests have worsened, with serum bilirubin levels rising to 4.5 mg/dL and aspartate aminotransferase (AST) climbing to 400 U/L. These values suggest a progression towards acute liver injury, possibly exacerbated by the ongoing need for vasopressor support to maintain her mean arterial pressure above the critical threshold of 60 mmHg. The team deliberates the potential causes, including ischemic hepatitis secondary to hypoperfusion, and considers adjusting the medication regimen to minimize hepatotoxicity.
In light of these developments, the team revises the treatment plan to prioritize the stabilization of cerebral and hepatic functions. The delicate balance of managing fluid removal through CRRT, while preventing hemodynamic instability, remains a focal point. The challenge now is to optimize the patient's care without compromising any single organ system, requiring advanced critical thinking and seamless coordination among the multidisciplinary team. As the patient's condition remains precarious, ongoing communication with the family emphasizes the gravity of the situation and the need for shared decision-making regarding potential outcomes and care goals.